Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Oncolytic Virus Therapy with HSV-1 for Hematologic Malignancies

Ryo Ishino, Yumi Kawase, MD, Toshio Kitawaki, MD PhD, Naoshi Sugimoto, MD PhD, Maki Oku, MD, Shumpei Uchida, MD, Osamu Imataki, MD PhD, Akihito Matsuoka, MD PhD, Teruhisa Taoka, MD PhD, Kimihiro Kawakami, MD PhD, Tomoki Todo, MD PhD, Akifumi Takaori-Kondo, MD PhD, Norimitsu Kadowaki, MD PhD

Blood (2019) 134 (Supplement_1): 3242.

https://doi.org/10.1182/blood-2019-127754

Published: 2019

Journal Articles

Targeting CD38 high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells

Emma Nolan, BSc, Arwen Stikvoort, PhD, Mark Gurney, MD, Nutsa Burduli, BSc, Lucy Kirkham-McCarthy, MSc, John Daly, MSc, Niels W. C. J. Van De Donk, Tuna Mutis, MD PhD, Subhashis Sarkar, PhD, Michael E O'Dwyer, MD

Blood (2019) 134 (Supplement_1): 5536.

https://doi.org/10.1182/blood-2019-128605

Published: 2019

Journal Articles

Evaluation of Interaction Between NK Cells and Colorectal Carcinoma Cells for Development of NK Cell-Based Immunotherapy in Patients with Refractory Disease

Elisabetta Todisco, MD, Ilaria Turin, Federica Ferulli, Matteo Tanzi, Silvia Brugnatelli, Sara Delfanti, Marcello Maestri, Matteo Donadon, Matteo Cimino, Guido Torzilli, Armando Santoro, MD, Paolo Pedrazzoli, Daniela Montagna

Blood (2014) 124 (21): 5810.

https://doi.org/10.1182/blood.V124.21.5810.5810

Published: 2014

Journal Articles

NK Cell Mediated Cytotoxicity Against Malignant Promyelocytes Enhanced By Arsenic Trioxide: Potential Clinical Relevance

Ansu Abu Alex, MSc, Hamenth Kumar P, MSc, Saravanan Ganesan, MSc, Nithya Balasundaram, MSc, Kavitha M Lakshmi, MSc, Biju George, MD, Aby Abraham, MD, Auro Viswabandya, MD, Alok Srivastava, MD, Rose Ann Padua, PhD, Christine Chomienne, MD, PhD, Poonkuzhali Balasubramanian, Ph.D, Vikram Mathews, MD

Blood (2013) 122 (21): 1455.

https://doi.org/10.1182/blood.V122.21.1455.1455

Published: 2013

Journal Articles

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

Caroline Veuillen, PhD, Jerome Rey, MD, Rémy Castellano, PhD, Florence Orlanducci, Françoise Mallet, Sylvaine Just-Landi, Diane Coso, MD, Vadim Ivanov, MD, PhD, Xavier Carcopino, MD, Reda Bouabdallah, MD, Yves Collette, PhD, Cyril Fauriat, PhD, Daniel Olive, MD, PhD, Thérèse Aurran, MD

Blood (2011) 118 (21): 3876.

https://doi.org/10.1182/blood.V118.21.3876.3876

Published: 2011

Journal Articles

DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK–T cell interaction

Michele Ardolino, Alessandra Zingoni, Cristina Cerboni, Francesca Cecere, Alessandra Soriani, Maria Luisa Iannitto, Angela Santoni

Blood (2011) 117 (18): 4778–4786.

https://doi.org/10.1182/blood-2010-08-300954

Published: 2011

Includes: Supplemental data

Journal Articles

Lenalidomide In Combination with Zoledronic Acid Restores the Activation and Anti-Myeloma Effects of γδT Cells Attenuated by the Bone Marrow Microenvironment

Qu Cui, MD, Masahiro Abe, MD, PhD, Hirokazu Miki, MD, Shingen Nakamura, MD, Keiichiro Watanabe, DDS, Akishige Ikegame, Masahiro Hiasa, DDS, PhD, Ayako Nakano, MD, PhD, Takeshi Harada, MD, Shiro Fujii, MD, Kumiko Kagawa, MD, Kyoko Takeuchi, MD, PhD, Shuji Ozaki, MD, PhD, Toshio Matsumoto, MD, PhD

Blood (2010) 116 (21): 3025.

https://doi.org/10.1182/blood.V116.21.3025.3025

Published: 2010

Journal Articles

Analysis of NK Cells Receptors and NK Cells Ligands in Acute Myeloid Leukemia: Comparisons Between the Blood and the Bone Marrow.

Jerome Rey, Eloise Perrot, Caroline Veuillen, Thomas Prébet, MD, Anne Etienne, Aude Charbonnier, Evelyne D'Incan, Norbert Vey, Daniel Olive, MD, PhD

Blood (2009) 114 (22): 1643.

https://doi.org/10.1182/blood.V114.22.1643.1643

Published: 2009

Journal Articles

An Unusual Expression: The Tumour Antigen SSX2IP Is Preferentially Expressed on the Surface of Acute Myeloid Leukaemia Cells during Early Mitosis.

Frances A.K. Denniss, BA, Nicola R. Hardwick, B.Sc., M.Phil, Ghulam J. Mufti, DM, FRCPath, Barbara A. Guinn, B.Sc., Ph.D.

Blood (2006) 108 (11): 4305.

https://doi.org/10.1182/blood.V108.11.4305.4305

Published: 2006

Journal Articles

The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8 + T-cell responses through the cell-surface receptor CRTAM

Kent S. Boles, Winfried Barchet, Tom Diacovo, Marina Cella, Marco Colonna

Blood (2005) 106 (3): 779–786.

https://doi.org/10.1182/blood-2005-02-0817

Published: 2005

Includes: Supplemental data

Journal Articles

Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)

Daniela Pende, Grazia Maria Spaggiari, Stefania Marcenaro, Stefania Martini, Paola Rivera, Andrea Capobianco, Michela Falco, Edoardo Lanino, Ivana Pierri, Renato Zambello, Andrea Bacigalupo, Maria Cristina Mingari, Alessandro Moretta, Lorenzo Moretta

Blood (2005) 105 (5): 2066–2073.

https://doi.org/10.1182/blood-2004-09-3548

Published: 2005

NARROW

Oncolytic Virus Therapy with HSV-1 for Hematologic Malignancies

Targeting CD38 high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells

Evaluation of Interaction Between NK Cells and Colorectal Carcinoma Cells for Development of NK Cell-Based Immunotherapy in Patients with Refractory Disease

NK Cell Mediated Cytotoxicity Against Malignant Promyelocytes Enhanced By Arsenic Trioxide: Potential Clinical Relevance

Defective Triggering of NK Cells Results in Primary CLL Cells Resistance to Cytotoxicity,

DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK–T cell interaction

Lenalidomide In Combination with Zoledronic Acid Restores the Activation and Anti-Myeloma Effects of γδT Cells Attenuated by the Bone Marrow Microenvironment

Analysis of NK Cells Receptors and NK Cells Ligands in Acute Myeloid Leukemia: Comparisons Between the Blood and the Bone Marrow.

An Unusual Expression: The Tumour Antigen SSX2IP Is Preferentially Expressed on the Surface of Acute Myeloid Leukaemia Cells during Early Mitosis.

The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8 + T-cell responses through the cell-surface receptor CRTAM

Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only